Ein Unternehmen der RHÖN-KLINIKUM AG

Publikationen 2017

Verburg FA, Luster M. 
Thyroid cancer: Redifferentiation - a 'new' option for (131)I-negative DTC.
Nat Rev Endocrinol. 2016 Nov 11.

Verburg FA, Luster M. 
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1611-1613. doi: 10.1007/s00259-017-3767-4. Epub 2017 Jul 4.

Reviews 2017

Verburg FA, Hänscheid H, Luster M.
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer.

Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):279-290. doi: 10.1016/j.beem.2017.04.010. Epub 2017 May 9.

Luster M, Pfestroff A, Verburg FA.
Recent advances in nuclear medicine in endocrine oncology.

Curr Opin Oncol. 2017 Jan;29(1):1-6.

Luster M, Pfestroff A, Hänscheid H, Verburg FA.
Radioiodine Therapy.

Semin Nucl Med. 2017 Mar;47(2):126-134. doi: 10.1053/j.semnuclmed.2016.10.002. Epub 2016 Nov 1.

Verburg FA, Van Santen HM, Luster M.
Pediatric papillary thyroid cancer: current management challenges.
Onco Targets Ther. 2016 Dec 28;10:165-175. doi: 10.2147/OTT.S100512. eCollection 2017.